RWA
ABBV icon

Redmont Wealth Advisors’s AbbVie ABBV Stock Holding History

Redmont Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$25.9K Sell
113
-65
-37% -$14.8K 0.04% 123
2025
Q3 		$41.1K Buy
178
+77
+76% +$15.7K 0.06% 107
2025
Q2 		$18.7K Buy
+101
New +$18.8K 0.03% 144
2024
Q4 		– Sell
-101
Closed -$19.9K – 64
2024
Q3 		$19.9K Hold
101
– – 0.03% 138
2024
Q2 		$17.3K Sell
101
-100
-50% -$16.6K 0.03% 146
2024
Q1 		$36.6K Buy
+201
New +$34.6K 0.05% 108
2023
Q1 		– Sell
-3,707
Closed -$599K – 61
2022
Q4 		$599K Buy
3,707
+100
+3% +$15.3K 0.7% 32
2022
Q3 		$484K Sell
3,607
-1,220
-25% -$175K 0.63% 38
2022
Q2 		$739K Sell
4,827
-12
-0.2% -$1.83K 0.9% 24
2022
Q1 		$785K Buy
4,839
+622
+15% +$90.4K 0.84% 26
2021
Q4 		$571K Buy
+4,217
New +$498K 0.61% 42

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Redmont Wealth Advisors's ABBV Position: Q4 2025 in Review

Redmont Wealth Advisors reduced its AbbVie (ABBV) stake by 37% in Q4 2025, selling an estimated $14.8K and leaving 113 shares worth $25.9K. The position accounts for 0.04% of the portfolio, ranked #123.

Redmont Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 11 quarters since. The position peaked at $785K in Q1 2022. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Redmont Wealth Advisors held 113 shares of AbbVie worth $25.9K as of Q4 2025.
  • Redmont Wealth Advisors sold 65 AbbVie shares in Q4 2025, an estimated $14.8K.
  • AbbVie made up 0.04% of Redmont Wealth Advisors's portfolio in Q4 2025, its #123 holding.
  • Redmont Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 11 quarters since.
  • Redmont Wealth Advisors's AbbVie position peaked at $785K in Q1 2022.
  • 4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Redmont Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.